Skip to main content

Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Orally Administered APX3330 in Subjects with Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy and Mild Proliferative Diabetic Retinopathy

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Ocuphire Pharma, Inc.

Start Date

January 5, 2021

End Date

February 28, 2023
 

Administered By

Ophthalmology

Awarded By

Ocuphire Pharma, Inc.

Start Date

January 5, 2021

End Date

February 28, 2023